KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Emergent Health Corp. (Other OTC:EMGE) announces it has increased its revenues from first half of 2008 to first half of 2009 by 82%, producing an unaudited net profit of $0.001 per share before taxes. Continued progress is anticipated and based upon it reaching the $100,000,000 sales mark at some point in the future, plus maintaining its current profit margin, profits of up to $20,000,000 could be achievable with appropriate capital and market penetration. This is also based upon the current market for products that increase adult stem cells through prescription already being in excess of $4 Billion with AMGEN; symbol AMGN, being the leader.
